Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

The Novel Deacetylase Inhibitor AR-42 Demonstrates Pre-Clinical Activity in B-Cell Malignancies In Vitro and In Vivo

  • David M. Lucas,

    Affiliations Department of Internal Medicine, The Ohio State University, Columbus, Ohio, United States of America, College of Pharmacy, The Ohio State University, Columbus, Ohio, United States of America

  • Lapo Alinari,

    Affiliation Department of Internal Medicine, The Ohio State University, Columbus, Ohio, United States of America

  • Derek A. West,

    Affiliation Department of Internal Medicine, The Ohio State University, Columbus, Ohio, United States of America

  • Melanie E. Davis,

    Affiliation Department of Internal Medicine, The Ohio State University, Columbus, Ohio, United States of America

  • Ryan B. Edwards,

    Affiliation Department of Internal Medicine, The Ohio State University, Columbus, Ohio, United States of America

  • Amy J. Johnson,

    Affiliation Department of Internal Medicine, The Ohio State University, Columbus, Ohio, United States of America

  • Kristie A. Blum,

    Affiliation Department of Internal Medicine, The Ohio State University, Columbus, Ohio, United States of America

  • Craig C. Hofmeister,

    Affiliation Department of Internal Medicine, The Ohio State University, Columbus, Ohio, United States of America

  • Michael A. Freitas,

    Affiliation Department of Molecular Virology, Immunology, and Medical Genetics, The Ohio State University, Columbus, Ohio, United States of America

  • Mark R. Parthun,

    Affiliation Department of Molecular and Cellular Biochemistry, The Ohio State University, Columbus, Ohio, United States of America

  • Dasheng Wang,

    Affiliation College of Pharmacy, The Ohio State University, Columbus, Ohio, United States of America

  • Amy Lehman,

    Affiliation Center for Biostatisics, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, United States of America

  • Xiaoli Zhang,

    Affiliation Center for Biostatisics, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, United States of America

  • David Jarjoura,

    Affiliation Center for Biostatisics, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, United States of America

  • Samuel K. Kulp,

    Affiliation College of Pharmacy, The Ohio State University, Columbus, Ohio, United States of America

  • Carlo M. Croce,

    Affiliation Department of Molecular Virology, Immunology, and Medical Genetics, The Ohio State University, Columbus, Ohio, United States of America

  • Michael R. Grever,

    Affiliations Department of Internal Medicine, The Ohio State University, Columbus, Ohio, United States of America, College of Pharmacy, The Ohio State University, Columbus, Ohio, United States of America

  • Ching-Shih Chen,

    Affiliation College of Pharmacy, The Ohio State University, Columbus, Ohio, United States of America

  • Robert A. Baiocchi ,

    Contributed equally to this work with: Robert A. Baiocchi, John C. Byrd

    Affiliation Department of Internal Medicine, The Ohio State University, Columbus, Ohio, United States of America

  •  [ ... ],
  • John C. Byrd

    Contributed equally to this work with: Robert A. Baiocchi, John C. Byrd

    john.byrd@osumc.edu

    Affiliations Department of Internal Medicine, The Ohio State University, Columbus, Ohio, United States of America, College of Pharmacy, The Ohio State University, Columbus, Ohio, United States of America

  • [ view all ]
  • [ view less ]

Viewed

Cited

Saved

Discussed

Powered by Altmetric
Questions or concerns about usage data? Please let us know.